Stay updated by reading our latest news

Research conducted at the University Hospital Geneva aimed to investigate the potential correlation between symptom burden reported through electronic patient-reported outcomes (ePRO) and the serological response to SARS-CoV-2 vaccines on cancer patients. The promising results are presented at ASCO 2022 this week. The results show that a machine learning model based on patient-reported symptom data...

Kaiku Health is taking part in a study assessing the use of an electronic Patient-Reported Outcome (ePRO)-based model of care to evaluate onset of symptomatic immune-related adverse events in cancer patients and their detection by healthcare providers. This phase-II randomised controlled trial, comparing the ePRO-based model of care to the current standard model of care,...

Kaiku Health, a leading digital therapeutics platform in cancer care, and Roche, a leading global healthcare company, are entering a strategic partnership in digital patient monitoring and management (DPMM). Kaiku Health and Roche aim to deploy digital tools to provide real-time symptom management by patients and Health Care Providers (HCPs), improve patient support, and provide...

Kaiku Health expansion around the world continues as Leben Salud becomes the first user of Kaiku Health in South America. The Argentinian hospital went live with Kaiku Health in November 2021 and currently uses the digital therapeutics platform in radiotherapy.  Located in the Patagonia region in Argentina, Leben Salud treats thousands of cancer patients each...

Kaiku Health user support for health care providers has joined Elekta Care Support Center (ECSC) in Europe. As of January 24th 2022, ECSC provides technical assistance to Kaiku Health customers in the region. This excludes the Nordic countries that will join the Care Support Center later in the year. With ECSC, the healthcare personnel users...